Putting the Dough in the Donut Hole: Big Pharma Hits the Sweet Spot in the Reform Debate

It's not often than any industry group voluntarily agrees to give up $80 billion in future revenues, but that's what the Pharmaceutical Research & Manufacturers of America is pledging to do to in the context of the health care reform debate. There are a lot of details to work out, but this is a case where what is important is not what PhRMA is giving-but what it gets.

There are a lot of things the members of the Pharmaceutical Research & Manufacturers of America would like to spend $80 billion on.

That sum of money is more than enough to fund a year’s worth of R&D worldwide, plus about 30%. It...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet